Barclays Assists in Exploring Sale of High Street Drug Retail and Wholesale Group
- US-based owner McKesson explores sale of Lloyds Pharmacy’s UK operations
- Barclays assisting in securing a sale amid industry concerns
- Lloyds Pharmacy operates over 1,400 sites and employs 17,000 people
- Possible sale could fetch £400m
- Industry facing financial challenges
US-based McKesson, the owner of Lloyds Pharmacy, is reportedly working with Barclays to explore the sale of its British operations amid concerns about the industry’s financial viability. The group operates over 1,400 sites across the UK and employs more than 17,000 people. The entirety of its UK operations could fetch a price tag of approximately £400m despite recent challenges faced by the sector. It is unclear whether McKesson plans to sell its entire UK portfolio or just the Lloyds arm.
Factuality Level: 8
Factuality Justification: The article provides accurate and objective information about McKesson exploring the sale of its British operations, mentions relevant details such as the number of sites and employees, and includes recent financial challenges faced by Lloyds Pharmacy. However, it lacks some specifics on the potential sale value and whether the entire UK portfolio or just the Lloyds arm is being sold.
Noise Level: 4
Noise Justification: The article provides relevant information about McKesson exploring the sale of its British operations and mentions some financial details, but lacks in-depth analysis or exploration of long-term trends or consequences. It also does not offer actionable insights or new knowledge.
Financial Relevance: Yes
Financial Markets Impacted: UK pharmacy sector and related companies
Financial Rating Justification: The article discusses the potential sale of Lloyds Pharmacy’s UK operations, which could impact the financial markets and companies in the UK pharmacy sector.
Presence Of Extreme Event: No
Nature Of Extreme Event: No
Impact Rating Of The Extreme Event: No
Extreme Rating Justification:
www.retailsector.co.uk